These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20674150)

  • 1. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed?
    Novara G; Ficarra V; Antonelli A; Artibani W; Bertini R; Carini M; Cosciani Cunico S; Imbimbo C; Longo N; Martignoni G; Martorana G; Minervini A; Mirone V; Montorsi F; Schiavina R; Simeone C; Serni S; Simonato A; Siracusano S; Volpe A; Carmignani G;
    Eur Urol; 2010 Oct; 58(4):588-95. PubMed ID: 20674150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.
    Frank I; Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2005 Jun; 173(6):1889-92. PubMed ID: 15879769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.
    Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS
    Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.
    Siemer S; Lehmann J; Loch A; Becker F; Stein U; Schneider G; Ziegler M; Stöckle M
    J Urol; 2005 Jan; 173(1):33-7. PubMed ID: 15592020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive ability of the 2002 and 2010 versions of the Tumour-Node-Metastasis classification system regarding metastasis-free, cancer-specific and overall survival in a European renal cell carcinoma single-centre series.
    Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Groselj-Strele A; Pummer K; Zigeuner R
    BJU Int; 2013 Apr; 111(4 Pt B):E191-5. PubMed ID: 23107473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reclassification of the current tumor, node, metastasis staging in pT3 renal cell carcinoma.
    Fujita T; Iwamura M; Yanagisawa N; Muramoto M; Okayasu I; Baba S
    Int J Urol; 2008 Jul; 15(7):582-6. PubMed ID: 18479355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Validation of 2009 TNM classification based on a prognostic analysis of 350 patients treated for renal cell carcinoma].
    Yasunaga Y; Komori K; Harada Y; Tohda A; Oka T
    Nihon Hinyokika Gakkai Zasshi; 2012 May; 103(3):540-7. PubMed ID: 22876658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.
    Shariat SF; Zigeuner R; Rink M; Margulis V; Hansen J; Kikuchi E; Kassouf W; Raman JD; Remzi M; Koppie TM; Bensalah K; Guo CC; Mikami S; Sircar K; Ng CK; Haitel A; Kabbani W; Chun FK; Wood CG; Scherr DS; Karakiewicz PI; Langner C
    Eur Urol; 2012 Aug; 62(2):224-31. PubMed ID: 22285763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients?
    Gofrit ON; Shapiro A; Pizov G; Landau EH; Katz R; Zorn KC; Pode D
    J Urol; 2007 May; 177(5):1682-6. PubMed ID: 17437782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
    Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
    Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma.
    Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Groselj-Strele A; Hoefler G; Pummer K; Zigeuner R
    Histopathology; 2013 Jan; 62(2):237-46. PubMed ID: 23020176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma.
    Siddiqui SA; Frank I; Leibovich BC; Cheville JC; Lohse CM; Zincke H; Blute ML
    J Urol; 2007 Jan; 177(1):59-62. PubMed ID: 17162000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposal of an improved prognostic classification for pT3 renal cell carcinoma.
    Terrone C; Gontero P; Volpe A; Porpiglia F; Bollito E; Zattoni F; Frea B; Tizzani A; Fontana D; Scarpa RM; Rossetti SR
    J Urol; 2008 Jul; 180(1):72-8. PubMed ID: 18485380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent.
    Gilbert SM; Murphy AM; Katz AE; Goluboff ET; Sawczuk IS; Olsson CA; Benson MC; McKiernan JM
    Urology; 2006 Aug; 68(2):287-91. PubMed ID: 16904438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients.
    Ficarra V; Galfano A; Guillé F; Schips L; Tostain J; Mejean A; Lang H; Mulders P; De La Taille A; Chautard D; Descotes JL; Cindolo L; Novara G; Rioux-Leclercq N; Zattoni F; Artibani W; Patard JJ
    J Urol; 2007 Aug; 178(2):418-24; discussion 423-4. PubMed ID: 17561128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.